Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Stock Forecast

Stock Price Forecast

The 12 analysts that cover Viridian Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $41.42, which forecasts a 47.43% increase in the stock price over the next year. The lowest target is $29 and the highest is $61.

Price Target: $41.42 (+47.43%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$29	$41.42	$42	$61
Change	+3.22%	+47.43%	+49.49%	+117.12%

Analyst Ratings

The average analyst rating for Viridian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	5	4	6	5	6	6
Buy	5	5	4	6	6	6
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	10	11	12	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Strong Buy Reiterates $42	Strong Buy	Reiterates	$42	+49.49%	Feb 4, 2026
Derek Archila Wells Fargo	Wells Fargo	Hold Maintains $26 → $29	Hold	Maintains	$26 → $29	+3.22%	Feb 3, 2026
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $41 → $40	Strong Buy	Maintains	$41 → $40	+42.37%	Jan 8, 2026
Michael Yee UBS	UBS	Strong Buy Initiates $50	Strong Buy	Initiates	$50	+77.97%	Jan 7, 2026
Serge Belanger Needham	Needham	Strong Buy Maintains $34 → $42	Strong Buy	Maintains	$34 → $42	+49.49%	Dec 23, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

79.07M

Increased by 26,080.79%

from 302.00K

Revenue Next Year

80.70M

Increased by 2.07%

from 79.07M

EPS This Year

-4.12

from -3.07

EPS Next Year

-3.76

from -4.12

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.05M	2.96M	1.77M	314.00K	302.00K	79.07M	80.70M
Revenue Growth	-76.46%	182.19%	-40.20%	-82.28%	-3.82%	26,080.79%	2.07%
EPS	-31.13	-6.66	-2.71	-3.91	-3.07	-4.12	-3.76
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	132.0M	217.7M
Avg	79.1M	80.7M
Low	289,100	14.8M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	43,608.6%	175.3%
Avg	26,080.8%	2.1%
Low	-4.3%	-81.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-3.35	-2.45
Avg	-4.12	-3.76
Low	-4.66	-4.64

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.